Malinao, Merlebeth E.
HRN: 20-04-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
AMPICILLIN 1GM (VIAL)
07/09/2025
07/11/2025
IV
2g
Q6
PROM
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: